Beruflich Dokumente
Kultur Dokumente
,
Docherty, A. J. P. and Murphy, G. (2000). The in vitro activity of ADAM-10 is
inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473, 275 -279
Ashcroft, G.S., Mills, S.J., Lei, K., Gibbons, L., Jeong, M.J., Tanigucji, M. et al. Estrogen
modulates cutaneous wound healing by downregulating macrophage migration
inhibitory factor. J Clin Invest. 2003; 111: 1309–1318
Bigg, H., Morrison, C., Butler, G., Bogoyevitch, M., Wang, Z., Soloway, P. D. and
Overall, C. ( 2001). Tissue inhibitor of metalloproteinases-4 inhibits but does not
support the activation of gelatinase A via efficient inhibition of membrane type 1-
matrix metalloproteinase. Cancer Res. 61, 3610 -3618..
Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a
systematic review. Lancet. 2000 Aug 12; 356(9229):535–9. [PubMed: 10950229]
Chung HW, Wen Y, Nezhat C, Woo BH, Polan ML. Matrix metalloproteinase-9 (MMP-9)
and tissue inhibitor of metalloproteinase-3 (TIMP-3) m-RNA expression in
endometriosis: MMP- 9/TIMP-3 ratio in ectopic and eutopic endometrium. Fertil
Steril 2001 (in press.
Daley JM, Reichner JS, Mahoney EJ, Manfield L, Henry WL, Mastrofrancesco B et al.
(2005) Modulation of macrophage phenotype by soluble products released form
neutrophils. J Immunol 174:2265–72
Dhital R, Otsuka K, Poudel KC, Yasuoka J, Dangal G, Jimba M. Improved quality of life
after surgery for pelvic organ prolapse in Nepalese women. BMC Women’s Health.
2013;13:22. [cited 2013 December 10].
Available from http://www.biomedcentral.com/1472-6874/13/22. doi:10.1186/1472-
6874-13-22
Jelovsek JE, Maher C, Barber MD, elvic Organ Prolapse. The Lancet 2007; 369;1027-
1038. Doi: 10.1016/S0140-6736(07)60462-00
Kerkhof MH, Hendriks L, Brölmann HA. Changes in connective tissue in patients with
pelvic organ prolapse—a review of the current literature. Int Urogynecol J Pelvic
Floor Dysfunct. 2009;20(4):461–474. doi: 10.1007/s00192-008-0737-
1. [PubMed] [Cross Ref]
Richter HE, Varner RE. Pelvic organ prolapse. In: Berek JS, editor. Berek and Novak’s
Gynecology. 14th ed. USA: Lippincott Williams and Wilkins;2007.p.897-934.
Schluter PJ. Abdominal sacral co lpopexy or vaginal sa cro spinous colpopexy for
vaginal vault prolapse: A prospective randomized study. American Journal of
Obstetrics & Gynecology 2004;190(1):20-6
Spath MA, Feuth TB, Smits APT, et al. Predictors and risk model development for
menopausal age in fragile × premutation carriers. Genet Med. 2011;13(7):643–
650. doi: 10.1097/GIM.0b013e31821705e5.[PMC free article] [PubMed] [Cross
Ref]
Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vittinghoff E, Brown JS. Cost of
pelvic organ prolapse surgery in the United States. Obstet Gynecol. 2001;98:646–
651. [PubMed]
Weber AM, Walters MD, Piedmonte MR, Ballard LA. Anterior colporrhaphy: a
randomized trial of three surgical techniques. Am J Obstet
Gynecol 2001;185:1299–304.
Zlotnik, A. and Yoshie, O.Chemokines: a new classification system and their role in
immunity, Immunity. 2000; 12: 121–127